DTL
RXRX icon

Dynamic Technology Lab’s Recursion Pharmaceuticals RXRX Stock Holding History

Dynamic Technology Lab’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,629
Closed -$303K – 1275
2023
Q2 		$303K Sell
40,629
-31,609
-44% -$221K 0.04% 701
2023
Q1 		$482K Buy
72,238
+47,686
+194% +$378K 0.04% 641
2022
Q4 		$189K Buy
+24,552
New +$241K 0.02% 926

Other funds holding RXRX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Dynamic Technology Lab's RXRX Position: Q3 2023 in Review

Dynamic Technology Lab sold out of Recursion Pharmaceuticals (RXRX) in Q3 2023, closing a stake of 40,629 shares — an estimated $303K sold.

Dynamic Technology Lab first reported a position in RXRX in Q4 2022 and held it in 3 quarters. The position peaked at $482K in Q1 2023. 192 funds tracked by Wall St. Rank hold RXRX as of Q3 2023.

  • Dynamic Technology Lab reported no remaining Recursion Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 40,629 Recursion Pharmaceuticals shares in Q3 2023, an estimated $303K.
  • Dynamic Technology Lab first reported a position in Recursion Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Dynamic Technology Lab's Recursion Pharmaceuticals position peaked at $482K in Q1 2023.
  • 192 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2023.

Based on Dynamic Technology Lab's 13F filing for Q3 2023, filed 14 Nov 2023.